ClinVar Miner

Submissions for variant NM_004329.3(BMPR1A):c.1473+1G>A

dbSNP: rs1589293533
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001011770 SCV001172130 likely pathogenic Hereditary cancer-predisposing syndrome 2021-06-15 criteria provided, single submitter clinical testing The c.1473+1G>A intronic variant results from a G to A substitution one nucleotide after coding exon 10 of the BMPR1A gene. This alteration occurs at the 3' terminus of the BMPR1A gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 11% of the protein. The exact functional effect of this alteration is unknown; however, a significant portion of the protein is affected (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.